This move is archived. Current quotes and coverage live on the stock page.
Get TELY alerts:
TelyRx Holdings Inc. shares surged nearly 8% in today's trading, fueled by exciting news and opportunities for investor engagement.
TelyRx Holdings Inc. (TELY.TO) saw its stock price jump by 7.92% in the last trading session, closing at CA$2.59. This impressive gain follows the company's upcoming presentation at the Small Cap Growth Virtual Investor Conference, which has sparked investor interest.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$65.94M
52W high
$4.25
52W low
$2.00
1W change
-4.00%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 150.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+150.0% Upside
Current Price
C$2.40
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
99.8%
Annualized
90-Day Vol
95.3%
Annualized
Trend (90d)
+17.9%
Annualized drift
90d Mean
C$2.56
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$2.45 | C$1.74 โ C$3.46 |
| 60 trading days | C$2.50 | C$1.54 โ C$4.08 |
| 90 trading days | C$2.56 | C$1.41 โ C$4.65 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors are responding positively to TelyRx's strategic engagement with the market, showing strong belief in the company's growth potential.
TelyRx Holdings Inc. Stock Rises by 7.92%
With a market cap of CA$58.47 million, TelyRx's stock performance reflects growing investor confidence in its business model and future prospects.
Bull case
The upcoming conference is a great chance for TelyRx to showcase its innovative healthcare solutions. This could attract new investors and drive the stock price even higher.
Bear case
Despite the positive momentum, TelyRx's lack of profitability and high market expectations could pose risks if the company doesn't meet investor hopes.
Advertisement
Investor Conference Sparks Interest
TelyRx's participation in the Small Cap Growth Virtual Investor Conference on June 4, 2026, is a key factor in its stock performance. The event allows investors to engage directly with company executives, promoting transparency and potential future growth. Such opportunities often boost investor confidence, as we saw in today's trading.
Market Reaction and Future Outlook
The 7.92% increase in TelyRx's stock price shows a positive market reaction to the company's strategic initiatives. However, investors should stay cautious. The company's current profit margin is negative, and while the conference may improve visibility, TelyRx needs to deliver tangible results to keep investor enthusiasm. For more insights on TelyRx, visit our detailed analysis here.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
